Despite being filed by the hundreds and thousands, lawsuits alleging injuries from exposure to toxic substances are notoriously difficult to win.

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

We believe Kenvue is in fine financial health. The firm ended 2024 with about $1.1 billion in cash and $8.6 billion in debt. Despite the large debt balance compared with its current level of cash, we ...

In an April 16 motion, Johnson & Johnson cited 'serious ethical lapses' that justified removing Beasley Allen from the talc ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

An appeal between a Georgia-Pacific LLC asbestos liability-holding unit and junior creditors offers another stab at success ...

Johnson & Johnson JNJ and AbbVie ABBV are two major U.S. pharmaceutical companies with robust pipelines and global operations. Both companies have a strong presence in immunology, oncology and ...

We recently published a list of Did Jim Cramer Hit or Miss On These 13 Stock Predictions? In this article, we are going to ...

After failing to resolve tens of thousands of talc lawsuits with three unsuccessful bankruptcy attempts, Johnson & Johnson is ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Johnson & Johnson cited an order last month that Moline reveal the names of the 33 individuals in her 2020 report, which linked mesothelioma to cosmetic talcum powder. Last year, a federal judge ...